Editas Medicine (EDIT) Asset Utilization Ratio (2016 - 2025)

Editas Medicine (EDIT) has 10 years of Asset Utilization Ratio data on file, last reported at 0.22 in Q3 2025.

• Asset Utilization Ratio for Q3 2025 came in at 0.22, up 29.75% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.22 (up 29.75% YoY), and the FY2024 annual result was 0.08, down 50.14% from the prior year.
• Asset Utilization Ratio advanced to 0.22 in Q3 2025 per EDIT's latest filing, from 0.16 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.22 in Q3 2025 and troughed at 0.03 in Q3 2021.
• A 5-year average of 0.1 and a median of 0.1 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio tumbled 77.26% in 2021, then jumped 323.12% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.04 in 2021, then rose by 2.94% to 0.04 in 2022, then surged by 312.75% to 0.16 in 2023, then plunged by 37.95% to 0.1 in 2024, then jumped by 132.95% to 0.22 in 2025.
• Business Quant data shows EDIT's Asset Utilization Ratio at 0.22 in Q3 2025, 0.16 in Q2 2025, and 0.12 in Q1 2025.